Research groups
Colleges
Philip Turner
B.Sc, Ph.D
Manager and Senior Researcher, NIHR Community Healthcare MIC
Biography
Manager and Senior Researcher, NIHR Community Healthcare MIC and Infections and Acute Care Research Group. From Jan 2018
Researcher and Industry Liaison, NIHR Diagnostics Evidence Cooperative Oxford. Nov 2014 - Dec 2017
Research Scientist, Department of Physiology, Anatomy and Genetics, University of Oxford. July 2009 - Nov 2014
PhD Cell Physiology, Department of Biology, University of York. Sept 2004 - Sept 2008
BSc (hons) Biological Sciences, School of Biology, University of Newcastle. Sept 1997 - July 2000
Research interests
The National Institute for Health Research (NIHR) Community Healthcare MedTech and In vitro Diagnostic Co-operative (MIC), focuses on the robust in-context evaluation and development of diagnostic devices and in vitro diagnostic tests of relevance to community healthcare. I am a diagnostics researcher and Manager of the Community Healthcare MIC. My role incorporates responsibility for liaising with members of the in vitro diagnostics industry and facilitating interactions with the MIC research team. My research has focussed on the diagnostic needs of clinicians, barriers to implementation, and the identification of evidence gaps which commonly exist in the evidence base for point-of-care diagnostic tests. I have a personal interest in IVDs which could be deployed in resource-limited settings.
My background is in cell physiology, membrane transport processes and signaling. I have a particular interest in the control of ventilation and in particular how humans respond to changes in the partial pressure of inspired oxygen. I have an associated interest in the physiology and medicine of life in remote regions and at high altitude.
Key publications
-
Journal article
Mallett S. et al, (2020), BMC Medicine, 18
-
Journal article
Pandit JJ. et al, (2020), Anesthesiology
-
Journal article
Verbakel JY. et al, (2019), BMJ Open, 9
-
Journal article
Lee JJ. et al, (2019), Clinical Infectious Diseases, 69, 24 - 33
-
Journal article
Abel L. et al, (2019), International Journal of Technology Assessment in Health Care, 35, 116 - 125
-
Journal article
Verbakel JY. et al, (2017), BMJ Open, 7
-
Journal article
Fanshawe TR. et al, (2018), Journal of Clinical Pathology, 71, 1065 - 1071
Recent publications
-
Journal article
Bird C. et al, (2023), Journal of the Pediatric Infectious Diseases Society
-
Journal article
Dixon S. et al, (2022), Antibiotics, 11
-
The Comparative Interrupted Time Series design for assessment of diagnostic impact: methodological considerations and an example using point-of-care C-Reactive Protein testing
Journal article
FANSHAWE T. et al, (2022), Diagnostic and Prognostic Research
-
Journal article
Butler J. et al, (2021), BMC Psychiatry, 21
-
Journal article
Hayward G. and Turner P., (2021), J Antimicrob Chemother
-
Journal article
O'donohoe P. et al, (2021), Journal of Anaesthesiology Clinical Pharmacology, 37, 509 - 516
-
Journal article
Nicholson BD. et al, (2021), Diagn Progn Res, 5